DE69333258D1 - Verwendung des Lysozym-dimers zur Herrstellung eines Arzneimittels zur modulation der naturlichen Abwehrvorgänge. - Google Patents

Verwendung des Lysozym-dimers zur Herrstellung eines Arzneimittels zur modulation der naturlichen Abwehrvorgänge.

Info

Publication number
DE69333258D1
DE69333258D1 DE69333258T DE69333258T DE69333258D1 DE 69333258 D1 DE69333258 D1 DE 69333258D1 DE 69333258 T DE69333258 T DE 69333258T DE 69333258 T DE69333258 T DE 69333258T DE 69333258 D1 DE69333258 D1 DE 69333258D1
Authority
DE
Germany
Prior art keywords
drug
produce
natural defense
lysozyme dimer
defense processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69333258T
Other languages
English (en)
Other versions
DE69333258T2 (de
Inventor
Witold Kiczka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIKA HEALTH PRODUCTS SPOLKA Z.O.O., KATY WROCL, PL
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of DE69333258D1 publication Critical patent/DE69333258D1/de
Application granted granted Critical
Publication of DE69333258T2 publication Critical patent/DE69333258T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69333258T 1992-07-13 1993-07-13 Verwendung von lysozymdimer zur herstellung eines arzneimittels zur modulation der natürlichen abwehrvorgänge Expired - Lifetime DE69333258T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL92295273A PL173978B1 (pl) 1992-07-13 1992-07-13 Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
PL29527392 1992-07-13
PCT/EP1993/001841 WO1994001127A1 (en) 1992-07-13 1993-07-13 Lysozyme dimer and compositions containing the same

Publications (2)

Publication Number Publication Date
DE69333258D1 true DE69333258D1 (de) 2003-11-27
DE69333258T2 DE69333258T2 (de) 2004-08-26

Family

ID=20058087

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0651654T Pending DE651654T1 (de) 1992-07-13 1993-07-13 Lysozym-dimer und zubereitungen die ihn enthalten.
DE69333258T Expired - Lifetime DE69333258T2 (de) 1992-07-13 1993-07-13 Verwendung von lysozymdimer zur herstellung eines arzneimittels zur modulation der natürlichen abwehrvorgänge

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE0651654T Pending DE651654T1 (de) 1992-07-13 1993-07-13 Lysozym-dimer und zubereitungen die ihn enthalten.

Country Status (31)

Country Link
US (1) US6132715A (de)
EP (1) EP0651654B1 (de)
JP (1) JPH07508744A (de)
KR (1) KR100289841B1 (de)
CN (1) CN1057937C (de)
AT (1) ATE252392T1 (de)
AU (1) AU677786B2 (de)
BG (1) BG63331B1 (de)
BR (1) BR9306722A (de)
CA (1) CA2140140A1 (de)
CZ (1) CZ286725B6 (de)
DE (2) DE651654T1 (de)
DK (1) DK0651654T3 (de)
ES (1) ES2074037T3 (de)
FI (1) FI950144A (de)
GE (1) GEP20012466B (de)
GR (1) GR950300039T1 (de)
HU (1) HU218151B (de)
MX (1) MX9304197A (de)
NZ (2) NZ254135A (de)
OA (1) OA10125A (de)
PL (1) PL173978B1 (de)
PT (1) PT651654E (de)
RO (1) RO112580B1 (de)
RU (1) RU2145875C1 (de)
SG (1) SG52727A1 (de)
SK (1) SK282377B6 (de)
TW (1) TW259710B (de)
UA (1) UA49789C2 (de)
WO (1) WO1994001127A1 (de)
ZA (1) ZA935046B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
WO1996038115A1 (en) * 1995-05-30 1996-12-05 Lectin Biopharma, Inc. Method of using lectins for agglutination and collection of menstrual flow
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
ITMI981148A1 (it) 1998-05-22 1999-11-22 Therapicon Srl Utilizzo di lisozima c modificato per preparare composizioni medicinali per il trattamento di alcune gravi malattie
EP1174147A1 (de) * 2000-06-27 2002-01-23 Nika Health Products Limited Antibiotikaresistanzumkehr mit Lysozymdimer
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
RU2472467C2 (ru) * 2011-04-13 2013-01-20 Государственное научное учреждение Краснодарский научно-исследовательский ветеринарный институт (ГНУ КНИВИ) Способ профилактики и лечения гастроэнтеритов, обусловленных бактериозами, у телят
RU2546911C2 (ru) * 2013-04-11 2015-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Донской государственный аграрный университет" Способ хранения свинины в охлажденном состоянии
CN105106626A (zh) * 2015-09-30 2015-12-02 成都倍加特生物科技有限公司 一种治疗月经期感染的汤剂药物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4020M (de) * 1965-01-29 1966-03-21
FR2215201A1 (en) * 1973-01-24 1974-08-23 Theranol Lab Broad-spectrum antibiotic compsns. - contg. antibiotic resistant lactic bacilli and enzyme diffusing-agent
JPS5533409A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Carcinostatic agent
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4457919A (en) * 1980-03-14 1984-07-03 Newport Pharmaceutical International, Inc. Method of imparting immunomodulating, antiviral or antitumor activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
US5200182A (en) * 1988-05-26 1993-04-06 Nika Health Products, Ltd. Antiviral or antibacterial composition and method of use
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel
DE68927733T2 (de) * 1988-05-31 1997-06-12 Napp Systems Inc Vorrichtung und verfahren zur behandlung von druckplatten
KR920702621A (ko) * 1989-06-13 1992-10-06 스튜어트 알. 슈터 단핵세포 및/또는 마크로파지에 의한 인터루킨-1 또는 종양회사인자 생성의 억제
DK0509984T3 (da) * 1990-01-08 1999-03-22 Nika Health Products Ltd Fremgangsmåde til fremstilling af lysozymdimer
US5314816A (en) * 1990-01-08 1994-05-24 Nika Health Products Ltd. Method of preparing lysozyme dimers
ATE161720T1 (de) * 1990-08-03 1998-01-15 Smithkline Beecham Corp Tnf-inhibitoren

Also Published As

Publication number Publication date
RO112580B1 (ro) 1997-11-28
BG63331B1 (bg) 2001-10-31
PT651654E (pt) 2004-03-31
PL295273A1 (en) 1994-01-24
ES2074037T1 (es) 1995-09-01
CZ8595A3 (en) 1995-09-13
CA2140140A1 (en) 1994-01-20
FI950144A0 (fi) 1995-01-12
JPH07508744A (ja) 1995-09-28
US6132715A (en) 2000-10-17
KR950702432A (ko) 1995-07-29
EP0651654B1 (de) 2003-10-22
BG99287A (bg) 1995-08-28
NZ254135A (en) 1996-11-26
GR950300039T1 (en) 1995-07-31
OA10125A (en) 1996-12-18
SK4095A3 (en) 1995-09-13
AU677786B2 (en) 1997-05-08
BR9306722A (pt) 1998-12-08
NZ299377A (en) 2001-02-23
DK0651654T3 (da) 2004-02-23
PL173978B1 (pl) 1998-05-29
ES2074037T3 (es) 2004-07-01
SK282377B6 (sk) 2002-01-07
KR100289841B1 (ko) 2001-05-15
UA49789C2 (uk) 2002-10-15
HU9500098D0 (en) 1995-03-28
AU4568693A (en) 1994-01-31
HU218151B (hu) 2000-06-28
SG52727A1 (en) 1998-09-28
MX9304197A (es) 1994-02-28
ATE252392T1 (de) 2003-11-15
ZA935046B (en) 1994-02-07
CN1087278A (zh) 1994-06-01
RU2145875C1 (ru) 2000-02-27
EP0651654A1 (de) 1995-05-10
WO1994001127A1 (en) 1994-01-20
DE69333258T2 (de) 2004-08-26
DE651654T1 (de) 1996-01-04
FI950144A (fi) 1995-01-12
HUT70973A (en) 1995-11-28
GEP20012466B (en) 2001-06-25
CN1057937C (zh) 2000-11-01
CZ286725B6 (en) 2000-06-14
TW259710B (de) 1995-10-11

Similar Documents

Publication Publication Date Title
DE69814917D1 (de) Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen
ATE199643T1 (de) Therapeutisches kombinationspräparat enthaltend interferon
DE69333626D1 (de) Verwendung von Adamantan Derivaten zur Herstellung eines Medikaments zur GLAUKOMBEHANDLUNG
DE69333258D1 (de) Verwendung des Lysozym-dimers zur Herrstellung eines Arzneimittels zur modulation der naturlichen Abwehrvorgänge.
DE3587941T2 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
ATE205389T1 (de) Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma
DE69230344D1 (de) Zusammensetzungen und methoden zur wundbehandlung
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
ATE131064T1 (de) Behandlung zur ermässigung von ödem und muskelschäden.
ATE23112T1 (de) Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks.
KR890000108A (ko) 종양 치료용 약제학적 조성물
MX9700967A (es) Uso terapeutico de acetazolamida para el tratamiento de edema cerebral.
SE7708176L (sv) Bensamidforeningar
DE69904712D1 (de) Verwendung von deltorphin zur behandlung von zytokin-vermittelter leberschädigung
DK0499679T3 (da) Terapeutisk middel til diabetisk gangræn
ATE337783T1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
Griffith Jr et al. Effect of Radon-Containing Ointment on Cutaneous Lymph Flow and Minute Vessels of Skin
Bronfenbrenner et al. Deleterious Effects of Local Application of Staphylococcus Bacteriophage.
RO81269B1 (ro) MEDICAMENT ACTIV îN TRATAMENTUL ARSURILOR SI PLAGILOR
DE3767055D1 (de) N-(2,6-dichlor-m-tolyl)anthranilsaeure (mechlophenaminsaeure) enthaltenden gel-arzneiform zur verwendung in der lokaltherapie.
GB545539A (en) A compound for use in the treatment of fractures, wounds, ulcers, skin diseases, skin eruptions and so forth
ATE172351T1 (de) Verwendung nadelloser druckmittelbetätigter injektions-geräte zur verabreichung von wirkstoffen an pflanzen
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
FR2329299A1 (fr) Argile contre le rhume, contre les rides. argile pour la glande thyroide

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DIE VERTRETER SIND ZU AENDERN IN: BECKER, KURIG, STRAUS, 80336 MUENCHEN

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NIKA HEALTH PRODUCTS SPOLKA Z.O.O., KATY WROCL, PL